Antibody plaque formation in vitro in the presence of respiration inhibitors.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells; D000963:Antimetabolites / Q000494:pharmacology*; D001386:Azides / Q000494:pharmacology; D002074:Butanones / Q000494:pharmacology; D002478:Cells, Cultured; D003486:Cyanides / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005461:Fluorine / Q000494:pharmacology; D006460:Hemolysin Proteins / Q000032:analysis; D006462:Hemolytic Plaque Technique; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D010101:Oxygen Consumption; D011188:Potassium / Q000494:pharmacology; D012402:Rotenone / Q000494:pharmacology; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000166:cytology; D013876:Thiophenes / Q000494:pharmacology
D000963:Antimetabolites; D001386:Azides; D002074:Butanones; D003486:Cyanides; D006460:Hemolysin Proteins; D013876:Thiophenes; D012402:Rotenone; D005461:Fluorine; D011188:Potassium